About Richard Freed, III
Form D filings for RheumaGen from 2022 to 2024 list Richard Freed, III as executive officer and director.
Richard Freed, III first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Richard Freed, III in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Richard Freed, III works with at each company, as listed on that company's latest Form D.
RheumaGen, Inc. · Form D, Apr 17, 2024
RH
Ryan Hart
Chief Legal Officer
BM
Bobak Mozayeni
Executive officer
BG
Bruce Goodwin
Director
TF
Thomas Fratacci
Director
BF
Brian Freed
Executive officer
JJ
James Hart, Jr.
Executive officer